MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 412591 | Name: Cervisol

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Cervisol is used in treatment of endometriosis; contains iron chloride, solution of picrinic acid in ethanol, & formalin.

Chemical Structure

Cervisol
CAS#8055-05-8

Theoretical Analysis

MedKoo Cat#: 412591

Name: Cervisol

CAS#: 8055-05-8

Chemical Formula: C8H9Cl3FeN3O8

Exact Mass: 435.8805

Molecular Weight: 437.37

Elemental Analysis: C, 21.97; H, 2.07; Cl, 24.32; Fe, 12.77; N, 9.61; O, 29.26

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Cervisol
IUPAC/Chemical Name
Phenol, 2,4,6-trinitro-, mixt. with ethanol and iron chloride
InChi Key
FFPRZNOIESDEQG-UHFFFAOYSA-K
InChi Code
InChI=1S/C6H3N3O7.C2H6O.3ClH.Fe/c10-6-4(8(13)14)1-3(7(11)12)2-5(6)9(15)16;1-2-3;;;;/h1-2,10H;3H,2H2,1H3;3*1H;/q;;;;;+3/p-3
SMILES Code
OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O.CCO.[Fe+3].[Cl-].[Cl-].[Cl-]
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 437.37 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Bocian J, Madej J, Krupiński L, Matuszewski H. Wartość kliniczna cervisolu w leczeniu erytroplakii cześci pochwowej macicy [Clinical value of Cervisol in the treatment of erosion of the vaginal part of the uterus]. Przegl Lek. 1967 Jun;23(6):530-3. Polish. PMID: 6056465. 2: Laskowski A. Odległe wyniki leczenia nadzerek szyjki macicy preparatem Cervisol [Late results of treatment of cervix erosion with Cervisol]. Pol Tyg Lek. 1975 Sep 8;30(36):1477-8. Polish. PMID: 1161607. 3: Nowak A, Drazkowski H. Leczenie powstałlej po elektrokoagulacji zewnetrznej endometriozy cześci pochwowej skaryfikacja z nastepowym przyzeganiem preparatem Cervisol [Scarification and consequent treatment with cervisol preparation in cases of external endometriosis of the vaginal portio consecutive to electrocoagulation]. Ginekol Pol. 1972 Apr;43(4):481-5. Polish. PMID: 4666607. 4: Madej J, Cielecki J, Bogdanowicz M. Dalsze doświadczenia kliniczne nad stosowaniem preparatu Cervisol w leczeniu ektopii cześci pochwowej szyjki macicy [Use of Cervisol in the treatment of uterine vaginal portio ectopia]. Ginekol Pol. 1974 Feb;45(2):217-22. Polish. PMID: 4813867.